Market Research Logo

Pulmonary/ Respiratory Drug Delivery

Pulmonary/ Respiratory Drug Delivery

Pulmonary/ Respiratory Drug Delivery market worldwide is projected to grow by US$20.6 Billion, driven by a compounded growth of 6.1%. Metered dose, one of the segments analyzed and sized in this study, displays the potential to grow at over 6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$42 Billion by the year 2025, Metered dose will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$964.3 Million to the region's size and clout in the next 5 to 6 years. Over US$959.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Metered dose will reach a market size of US$3.2 Billion by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$3.6 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, 3M Company; AstraZeneca PLC; Boehringer Ingelheim International GmbH; Cipla Ltd.; GlaxoSmithKline PLC; Merck & Co., Inc.; Novartis AG; Omron Corporation; Sunovion Pharmaceuticals, Inc.; Teva Pharmaceutical Industries Ltd.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Pulmonary/ Respiratory Drug Delivery Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Pulmonary/ Respiratory Drug Delivery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Pulmonary/ Respiratory Drug Delivery Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Pulmonary/ Respiratory Drug Delivery Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Metered dose (Device Type) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 5: Metered dose (Device Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 6: Metered dose (Device Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Dry Powder (Device Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 8: Dry Powder (Device Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 9: Dry Powder (Device Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Nebulizer (Device Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
TABLE 11: Nebulizer (Device Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
TABLE 12: Nebulizer (Device Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Accessories (Device Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
TABLE 14: Accessories (Device Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
TABLE 15: Accessories (Device Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Chronic Obstructive Pulmonary Disease (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 17: Chronic Obstructive Pulmonary Disease (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
TABLE 18: Chronic Obstructive Pulmonary Disease (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: Asthma (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
TABLE 20: Asthma (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
TABLE 21: Asthma (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
TABLE 22: Cystic Fibrosis (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
TABLE 23: Cystic Fibrosis (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 24: Cystic Fibrosis (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 25: Other Applications (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025
TABLE 26: Other Applications (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
TABLE 27: Other Applications (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Pulmonary/ Respiratory Drug Delivery Market Share (in %) by Company: 2019 & 2025
TABLE 28: United States Pulmonary/ Respiratory Drug Delivery Market Estimates and Projections in US$ Million by Device Type: 2018 to 2025
TABLE 29: Pulmonary/ Respiratory Drug Delivery Market in the United States by Device Type: A Historic Review in US$ Million for 2009-2017
TABLE 30: United States Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Device Type: 2009 VS 2019 VS 2025
TABLE 31: United States Pulmonary/ Respiratory Drug Delivery Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
TABLE 32: Pulmonary/ Respiratory Drug Delivery Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017
TABLE 33: Pulmonary/ Respiratory Drug Delivery Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
CANADA
TABLE 34: Canadian Pulmonary/ Respiratory Drug Delivery Market Estimates and Forecasts in US$ Million by Device Type: 2018 to 2025
TABLE 35: Canadian Pulmonary/ Respiratory Drug Delivery Historic Market Review by Device Type in US$ Million: 2009-2017
TABLE 36: Pulmonary/ Respiratory Drug Delivery Market in Canada: Percentage Share Breakdown of Sales by Device Type for 2009, 2019, and 2025
TABLE 37: Canadian Pulmonary/ Respiratory Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
TABLE 38: Pulmonary/ Respiratory Drug Delivery Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
TABLE 39: Canadian Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Application: 2009 VS 2019 VS 2025
JAPAN
TABLE 40: Japanese Market for Pulmonary/ Respiratory Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Device Type for the Period 2018-2025
TABLE 41: Pulmonary/ Respiratory Drug Delivery Market in Japan: Historic Sales Analysis in US$ Million by Device Type for the Period 2009-2017
TABLE 42: Japanese Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Device Type: 2009 VS 2019 VS 2025
TABLE 43: Japanese Demand Estimates and Forecasts for Pulmonary/ Respiratory Drug Delivery in US$ Million by Application: 2018 to 2025
TABLE 44: Japanese Pulmonary/ Respiratory Drug Delivery Market in US$ Million by Application: 2009-2017
TABLE 45: Pulmonary/ Respiratory Drug Delivery Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
CHINA
TABLE 46: Chinese Pulmonary/ Respiratory Drug Delivery Market Growth Prospects in US$ Million by Device Type for the Period 2018-2025
TABLE 47: Pulmonary/ Respiratory Drug Delivery Historic Market Analysis in China in US$ Million by Device Type: 2009-2017
TABLE 48: Chinese Pulmonary/ Respiratory Drug Delivery Market by Device Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 49: Chinese Demand for Pulmonary/ Respiratory Drug Delivery in US$ Million by Application: 2018 to 2025
TABLE 50: Pulmonary/ Respiratory Drug Delivery Market Review in China in US$ Million by Application: 2009-2017
TABLE 51: Chinese Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Application: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Pulmonary/ Respiratory Drug Delivery Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 52: European Pulmonary/ Respiratory Drug Delivery Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 53: Pulmonary/ Respiratory Drug Delivery Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 54: European Pulmonary/ Respiratory Drug Delivery Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 55: European Pulmonary/ Respiratory Drug Delivery Market Estimates and Forecasts in US$ Million by Device Type: 2018-2025
TABLE 56: Pulmonary/ Respiratory Drug Delivery Market in Europe in US$ Million by Device Type: A Historic Review for the Period 2009-2017
TABLE 57: European Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Device Type: 2009 VS 2019 VS 2025
TABLE 58: European Pulmonary/ Respiratory Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2018-2025
TABLE 59: Pulmonary/ Respiratory Drug Delivery Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
TABLE 60: European Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Application: 2009 VS 2019 VS 2025
FRANCE
TABLE 61: Pulmonary/ Respiratory Drug Delivery Market in France by Device Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 62: French Pulmonary/ Respiratory Drug Delivery Historic Market Scenario in US$ Million by Device Type: 2009-2017
TABLE 63: French Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Device Type: 2009 VS 2019 VS 2025
TABLE 64: Pulmonary/ Respiratory Drug Delivery Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
TABLE 65: French Pulmonary/ Respiratory Drug Delivery Historic Market Review in US$ Million by Application: 2009-2017
TABLE 66: French Pulmonary/ Respiratory Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
GERMANY
TABLE 67: Pulmonary/ Respiratory Drug Delivery Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Device Type for the Period 2018-2025
TABLE 68: German Pulmonary/ Respiratory Drug Delivery Historic Market Analysis in US$ Million by Device Type: 2009-2017
TABLE 69: German Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Device Type: 2009 VS 2019 VS 2025
TABLE 70: Pulmonary/ Respiratory Drug Delivery Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
TABLE 71: German Pulmonary/ Respiratory Drug Delivery Market in Retrospect in US$ Million by Application: 2009-2017
TABLE 72: Pulmonary/ Respiratory Drug Delivery Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
ITALY
TABLE 73: Italian Pulmonary/ Respiratory Drug Delivery Market Growth Prospects in US$ Million by Device Type for the Period 2018-2025
TABLE 74: Pulmonary/ Respiratory Drug Delivery Historic Market Analysis in Italy in US$ Million by Device Type: 2009-2017
TABLE 75: Italian Pulmonary/ Respiratory Drug Delivery Market by Device Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 76: Italian Demand for Pulmonary/ Respiratory Drug Delivery in US$ Million by Application: 2018 to 2025
TABLE 77: Pulmonary/ Respiratory Drug Delivery Market Review in Italy in US$ Million by Application: 2009-2017
TABLE 78: Italian Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Application: 2009 VS 2019 VS 2025
UNITED KINGDOM
TABLE 79: United Kingdom Market for Pulmonary/ Respiratory Drug Delivery: Annual Sales Estimates and Projections in US$ Million by Device Type for the Period 2018-2025
TABLE 80: Pulmonary/ Respiratory Drug Delivery Market in the United Kingdom: Historic Sales Analysis in US$ Million by Device Type for the Period 2009-2017
TABLE 81: United Kingdom Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Device Type: 2009 VS 2019 VS 2025
TABLE 82: United Kingdom Demand Estimates and Forecasts for Pulmonary/ Respiratory Drug Delivery in US$ Million by Application: 2018 to 2025
TABLE 83: United Kingdom Pulmonary/ Respiratory Drug Delivery Market in US$ Million by Application: 2009-2017
TABLE 84: Pulmonary/ Respiratory Drug Delivery Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 85: Rest of Europe Pulmonary/ Respiratory Drug Delivery Market Estimates and Forecasts in US$ Million by Device Type: 2018-2025
TABLE 86: Pulmonary/ Respiratory Drug Delivery Market in Rest of Europe in US$ Million by Device Type: A Historic Review for the Period 2009-2017
TABLE 87: Rest of Europe Pulmonary/ Respiratory Drug Delivery Market Share Breakdown by Device Type: 2009 VS 2019 VS 2025
TABLE 88: Rest of Europe Pulmonary/ Respiratory Drug Delivery Addressable Market Opportunity in US$ Million by Application: 2018-2025
TABLE 89: Pulmonary/ Respiratory Drug Delivery Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
TABLE 90: Rest of Europe Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Application: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 91: Pulmonary/ Respiratory Drug Delivery Market in Asia-Pacific by Device Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 92: Asia-Pacific Pulmonary/ Respiratory Drug Delivery Historic Market Scenario in US$ Million by Device Type: 2009-2017
TABLE 93: Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Device Type: 2009 VS 2019 VS 2025
TABLE 94: Pulmonary/ Respiratory Drug Delivery Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
TABLE 95: Asia-Pacific Pulmonary/ Respiratory Drug Delivery Historic Market Review in US$ Million by Application: 2009-2017
TABLE 96: Asia-Pacific Pulmonary/ Respiratory Drug Delivery Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
REST OF WORLD
TABLE 97: Rest of World Pulmonary/ Respiratory Drug Delivery Market Estimates and Forecasts in US$ Million by Device Type: 2018 to 2025
TABLE 98: Rest of World Pulmonary/ Respiratory Drug Delivery Historic Market Review by Device Type in US$ Million: 2009-2017
TABLE 99: Pulmonary/ Respiratory Drug Delivery Market in Rest of World: Percentage Share Breakdown of Sales by Device Type for 2009, 2019, and 2025
TABLE 100: Rest of World Pulmonary/ Respiratory Drug Delivery Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
TABLE 101: Pulmonary/ Respiratory Drug Delivery Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
TABLE 102: Rest of World Pulmonary/ Respiratory Drug Delivery Market Share Analysis by Application: 2009 VS 2019 VS 2025
IV. COMPETITION
3M COMPANY
ASTRAZENECA PLC
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CIPLA
GLAXOSMITHKLINE PLC
MERCK & CO.
NOVARTIS AG
OMRON CORPORATION
SUNOVION PHARMACEUTICALS
TEVA PHARMACEUTICAL INDUSTRIES
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report